News & Events
- NCATS Assay Guidance Workshop for High-Throughput Screening and Lead Discovery
- Society for Laboratory Automation and Screening (SLAS) 4th Annual Conference & Exhibition
- Fifth AIMBE/NIH Workshop on Validation and Qualification of New In Vitro Tools and Models for the Pre-clinical Drug Discovery Process
- Rare Disease Day 2015
Feb. 6, 2015
9 a.m. to 4:30 p.m. ET
9800 Medical Center Drive, Building B, Room 377
Rockville, Maryland 20850
NCATS and editors of the Assay Guidance Manual (an e-Book of best practices in quantitative biology and the development of robust assay methods) will host a workshop on assay development for high-throughput screening and lead discovery for NIH researchers. The goal is to share knowledge that enables investigators to begin developing a translational project or to better understand and improve an existing project. Identifying the best approach to assay development for a high-throughput screen or lead optimization can be a challenging; many of the methodologies used in such projects are “tribal knowledge” within the pharmaceutical industry and not readily available to others.
Space is limited to 30 individuals; seating is on a first-come, first-served basis. For security purposes, all attendees must register in advance. To register, send an e-mail to NCATS_AGM_Editors@mail.nih.gov including your name, Institute/Center and research interests. Registration will close Jan. 30, 2015.
Individuals with disabilities who need sign language interpreters and/or reasonable accommodation to participate in this workshop should contact Nathan P. Coussens at email@example.com, 301-217-5465 and/or the Federal Relay, 800-877-8339. Requests should be made at least five business days in advance of the event.
Feb. 7-11, 2015
Walter E. Washington Convention Center
801 Mount Vernon Place Northwest
Washington, D.C. 20001
SLAS presenters include National Institutes of Health (NIH) Director Francis S. Collins, M.D., Ph.D., and NCATS Director Christopher P. Austin, M.D. On Feb. 9, 2014, Dr. Austin also will chair An Evening with NIH, focused on NIH’s programs, services and capabilities.
An Evening with NIH
Monday, Feb. 9, 6:30-8:30 p.m. ET
- Facilitated Translation Within NCATS’ TRND and BrIDGs Programs Presenter: Nora Yang, Ph.D., NCATS
- NCATS SBIR and STTR Programs: Valuable Resources for Small Businesses Presenter: Lili M. Portilla, M.P.A., NCATS
- National Cancer Institute Experimental Therapeutics Program Presenter: Barbara Mroczkowski, Ph.D., NCI
- NIH-Industry Partnership to Discover New Therapeutic Uses for Existing Molecules Presenter: Christine M. Colvis, Ph.D., NCATS
Fifth AIMBE/NIH Workshop on Validation and Qualification of New In Vitro Tools and Models for the Pre-clinical Drug Discovery Process
Feb. 12, 2015
8 a.m. to 8 p.m. ET
National Institutes of Health
National Library of Medicine
Lister Hill Auditorium (Building 38A)
8600 Rockville Pike
Bethesda, Maryland 20894
NCATS, the American Institute for Medical and Biological Engineering (AIMBE), and the National Institute of Biomedical Imaging and Bioengineering will hold the fifth meeting in a series of workshops addressing validation and qualification of new in vitro tools and models for the pre-clinical drug discovery process. The overall goal of this series of workshops is to develop guidelines for investigators creating new tools for the pre-clinical (and possibly clinical) drug development process. These guidelines would address how to validate and qualify new technologies so that they become useful, meaningful tools. Previous meetings have focused on drug toxicity. The focus of the February meeting will be drug efficacy.Back to top
Feb. 27, 2015
8:30 a.m. to 5 p.m. ET
National Institutes of Health
Clinical Center (Building 10), Masur Auditorium
Bethesda, Maryland 20892
NIH will celebrate Rare Disease Day with a daylong event from 8:30 a.m. to 5 p.m. on Friday, Feb. 27, 2015. The event, which is sponsored by NCATS and the NIH Clinical Center, is free and open to the public. Rare Disease Day at NIH will provide information of interest to patients and patient advocates, health care providers, researchers, industry representatives and government employees, including presentations by academic and government scientists, industry representatives and the lay community. In addition to the scheduled talks, posters and exhibits from many groups relevant to the rare diseases research community will be displayed. The Rare Disease Day 2015 event also will be webcast, and Clinical Center tours will be available to in-person attendees.
May 27-28, 2015
Zuiderkerk, Amsterdam, NL
This conference will bring together key international stakeholders in translational research. Over two days, experts will present and discuss the main challenges in translational research, together with the new developments that EATRIS ERIC – the European Infrastructure for Translational Medicine, part of the European Research Infrastructure Consortium – contributes to the field. The conference will provide a unique opportunity to interact with a wide range of key stakeholders: patient organizations, research funders, and representatives from government industry and regulatory agencies.
On May 28, NCATS Director Christopher P. Austin, M.D., will serve as one of the keynote speakers during Session 4: Global Collaboration in Translational Medicine.
Please e-mail any questions to firstname.lastname@example.org.